Hodan Ali

Hodan Ali is the Global Study Associate Director at AstraZeneca, where they focus on bringing new therapies and ideas to market. With extensive experience in clinical and preclinical research, Hodan has demonstrated leadership in managing multiple clinical development programs while fostering collaboration across cross-functional teams. Previously, Hodan held research and managerial positions at various institutions, including Amplimmune, Inc. and Roche Molecular Systems, and has a B.A. in Biology from Rutgers University.